Rosales, Thinan L.
HRN: 27-96-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/19/2025
10/26/2025
IV
100mg
Q24
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes